As of June 2023 Aurobindo Pharma has a market cap of $4.71 Billion. This makes Aurobindo Pharma the world's 2514th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $4.71 B | 51.98% |
2022 | $3.10 B | -46.31% |
2021 | $5.78 B | -21.68% |
2020 | $7.38 B | 96.64% |
2019 | $3.75 B | -38.88% |
2018 | $6.14 B | -2.38% |
2017 | $6.29 B | 9.13% |
2016 | $5.76 B | -25.1% |
2015 | $7.69 B | 47.38% |
2014 | $5.22 B | 182.08% |
2013 | $1.85 B | 83.86% |
2012 | $1.00 B | 115.31% |
2011 | $0.46 B | -71.38% |
2010 | $1.63 B | 54.65% |
2009 | $1.05 B | 460.91% |
2008 | $0.18 B | -74.48% |
2007 | $0.73 B | -13.57% |
2006 | $0.85 B | 84.18% |
2005 | $0.46 B |
On Jun 2nd, 2023 the market cap of Aurobindo Pharma was reported to be: